Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lyndra Therapeutics
Biotech
Nortiva purrs into action with long-acting Lynx platform
Innoviva has revealed the next steps for Langer Lab assets it rescued from Lyndra’s collapse, launching Nortiva to develop long-acting oral medicines.
Nick Paul Taylor
Jun 18, 2026 8:00am
The 2025 Biotech Graveyard
Oct 31, 2025 5:00am
Takeda taps Julie Kim as new CEO—Chutes & Ladders
Jan 31, 2025 8:30am
Stanford president resigns—Chutes & Ladders
Jul 21, 2023 9:30am
Lyndra banks $61M to bring long-acting pill into pivotal trial
Jun 24, 2021 8:00am
Lyndra's long-acting schizophrenia med shows promise in phase 2
Apr 18, 2021 4:20pm